Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer
about
S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE)The human protein disulfide isomerase gene familyhAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycanMolecular basis for the nerve dependence of limb regeneration in an adult vertebrateProtein-centric N-glycoproteomics analysis of membrane and plasma membrane proteinsSuppression subtractive hybridization and expression profiling identifies a unique set of genes overexpressed in non-small-cell lung cancerInteraction of connexin43 and protein kinase C-delta during FGF2 signalingMARCKS-like protein, a membrane protein identified for its expression in developing neural retina, plays a role in regulating retinal cell proliferationAversive cues fail to activate fos expression in the asymmetric olfactory-habenula pathway of zebrafish.Integrated analysis of global mRNA and protein expression data in HEK293 cells overexpressing PRL-1.Feature extraction and quantification for mass spectrometry in biomedical applications using the mean spectrum.Proteomic analysis of the cell-surface membrane in chronic lymphocytic leukemia: identification of two novel proteins, BCNP1 and MIG2B.Evaluation of strategy for analyzing mouse liver plasma membrane proteome.Identification of genes differentially expressed as result of adenovirus type 5- and adenovirus type 12-transformation.Understanding the characteristics of mass spectrometry data through the use of simulation.Gene expression down-regulation in CD90+ prostate tumor-associated stromal cells involves potential organ-specific genesAn introspective comparison of random forest-based classifiers for the analysis of cluster-correlated data by way of RF++.Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomes.Searching for Potential Ovarian Cancer Biomarkers with Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.Discovery of pathway biomarkers from coupled proteomics and systems biology methodsThe value of serum biomarkers (Bc1, Bc2, Bc3) in the diagnosis of early breast cancer.Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection.Myoferlin depletion in breast cancer cells promotes mesenchymal to epithelial shape change and stalls invasionThe anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancerS100A14 interacts with S100A16 and regulates its expression in human cancer cells.Clinical proteomics: present and future prospects.Proteomic characterization of Her2/neu-overexpressing breast cancer cells.Pharmacoproteomics in drug development.Breast cancer: when proteomics challenges biological complexity.Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancerAGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection.Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM84B As A Biomarker In Predicting Pathological Response to Neoadjuvant ChemoradiationMechanistic modeling of the effects of myoferlin on tumor cell invasion.Anterior gradient protein 3 is associated with less aggressive tumors and better outcome of breast cancer patients.RASSF1A and the rs2073498 Cancer Associated SNPLarge-scale proteomic analysis of membrane proteins.Expression of AGR2 in pituitary adenomas and its association with tumor aggressivenessCD70 (TNFSF7) is expressed at high prevalence in renal cell carcinomas and is rapidly internalised on antibody binding.Breast cancer proteomics: clinical perspectives.
P2860
Q21135467-DBE2D6FB-0ADB-4A1B-8D8F-3B35B655FBD8Q21245448-9617EA30-E04D-44CF-BA29-9F3B4FA52F37Q24294965-B0C619AC-A5C4-44D1-BFEF-74E0C3C70331Q24645387-1F725FD2-0D4F-44E9-A9A8-CEA8DE2C9E5FQ27009121-0F9CC5B7-A1EB-4C03-B619-DF4946629EFDQ28279309-30495363-7AB6-4F75-B818-D5DABE63A37FQ28506823-9F4A1C5B-3DCD-4ABA-9E48-0C46E82CFB6DQ28586914-A311BBF6-FD8A-48DA-B7EC-7172E2CB1EEFQ30418949-D350C6C4-E062-4E64-98D7-DB908F20B2A6Q30665898-7F29CC52-480E-48BF-A535-87A9DB4E9FABQ31143825-A355D641-F1DB-4931-B57A-619CD83F28B2Q31151016-D478948D-C051-4484-B580-4B663BD9E772Q33306514-80001197-283D-434B-A628-0749003CC654Q33406639-57236FC2-243C-44BA-88B6-D7F9BEBC1661Q33420432-D32D6378-BB47-4155-9E66-14CFF991C2D6Q33500845-CC8FD266-EBDB-451F-AA87-5201DE198EADQ33504567-588DDF40-8859-4C51-98EB-ED889FAED2BAQ33519740-11DE13CB-46D2-484B-92AC-642FA1AD6BD3Q33642806-446947EE-1547-4556-B82E-51540323C479Q33737009-99787AC8-A822-4108-9416-2BE1FA6088E5Q33822314-201C08B5-7181-477B-B4BE-A25348621554Q33892389-CC16FEDA-C47F-4853-A08C-3DDC779CAC1DQ34143522-4223F1C6-E23E-4B75-A633-9E4A9F5BB0FEQ34326497-C0C532ED-CC29-4C5F-985A-A51F8E04187FQ34984679-1E98761E-50F8-4CEA-9C58-D6CF2A21C6EFQ35006163-873AB435-25D0-4F03-BD91-B414E0C6506CQ35053674-8BC31BDE-E0B1-4EBF-8FF0-0FEE4563C07CQ35082856-A8326FBE-0B4A-41C5-86EC-6FFB1C057DEAQ35127370-8B40CC63-B85F-4D5C-918D-F39ACA340101Q35140561-3A4935AB-B4E4-4EA9-A6E1-894AD5729A2BQ35189523-9A8F353A-E2C3-43D8-8CA5-7DC9BB75884DQ35432936-9A8901D2-997E-48D2-9C09-51318B1849A2Q35616720-CF1A0975-6D82-43E4-9CFB-2486E5976DF5Q35647790-D8E3EEB5-9C6A-406B-BCDF-8673A1025E14Q35799421-2338F266-C62E-4B84-983E-05D4EA850E64Q35971247-7745C11C-65F4-44DC-BF42-3923DD1505DEQ36168376-A941FC7D-71CF-4B9C-A2CC-27D6C2F45417Q36335461-799D3792-E367-404B-881D-69478E185742Q36612144-4644093A-32ED-4347-AB99-79F77813D4CCQ36717346-78A73B88-1D56-4334-9D3C-B3FD0588D9B4
P2860
Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Comprehensive proteomic analys ...... ntial roles in clinical cancer
@ast
Comprehensive proteomic analys ...... ntial roles in clinical cancer
@en
Comprehensive proteomic analys ...... ntial roles in clinical cancer
@en-gb
Comprehensive proteomic analys ...... ntial roles in clinical cancer
@nl
type
label
Comprehensive proteomic analys ...... ntial roles in clinical cancer
@ast
Comprehensive proteomic analys ...... ntial roles in clinical cancer
@en
Comprehensive proteomic analys ...... ntial roles in clinical cancer
@en-gb
Comprehensive proteomic analys ...... ntial roles in clinical cancer
@nl
prefLabel
Comprehensive proteomic analys ...... ntial roles in clinical cancer
@ast
Comprehensive proteomic analys ...... ntial roles in clinical cancer
@en
Comprehensive proteomic analys ...... ntial roles in clinical cancer
@en-gb
Comprehensive proteomic analys ...... ntial roles in clinical cancer
@nl
P2093
P2860
P356
P1476
Comprehensive proteomic analys ...... ntial roles in clinical cancer
@en
P2093
Alasdair Stamps
Graham C Fletcher
Graham Steers
Helen R Poyser
Joanne Berry
Jonathan A Terrett
Julie A Loader
Kerry L Tyson
Laurent Daviet
Lindsey Hudson
P2860
P304
P356
10.1074/JBC.M210184200
P407
P577
2003-02-21T00:00:00Z